Effect of Opioids on Central Control of Ventilation in Children With Obstructive Sleep Apnea
NCT ID: NCT05051189
Last Updated: 2025-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
90 participants
INTERVENTIONAL
2021-12-01
2024-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness Of Apneic Oxygenation During Induction Of General Anesthesia In Children
NCT06742476
Steroids for Pediatric Apnea Research in Kids
NCT02180672
Apnoeic Oxygenation During Pediatric Tracheal Intubation
NCT06576596
Caffeine in Children With Obstructive Sleep Apnea, Dose Response Study
NCT01349205
CPAP and Lateral Neck Rotation on Anesthetized Children
NCT00592423
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
1. patients with sleep study O2 nadir \>85%
2. patients with sleep study O2 nadir \<85%
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with sleep apnea having oxygen Saturation >85% randomized to fentanyl 1.0/kg
Children with OSA having procedures requiring endotracheal intubation and a who will receive opioids (1.0 mcg/kg fentanyl for IBW, max 25 mcg) for evaluation of respiratory changes.
Fentanyl Citrate
Ventilatory response to fentanyl in patients with OSA Specifically: respiratory changes, CO2, RR, TV
Patients with sleep apnea having oxygen Saturation <85% randomized to 1.0 mcg/kg fentanyl
Children without OSA having procedures requiring endotracheal intubation and an who will receive opioids (1.0 mcg/kg fentanyl for IBW, max 25 mcg) for evaluation of respiratory changes
Fentanyl Citrate
Ventilatory response to fentanyl in patients with OSA Specifically: respiratory changes, CO2, RR, TV
Patients with sleep apnea having oxygen Saturation >85% randomized to fentanyl 1.5/kg
Children with OSA having procedures requiring endotracheal intubation and a who will receive opioids (1.5 mcg/kg fentanyl for IBW, max 25 mcg) for evaluation of respiratory changes.
Fentanyl Citrate
Ventilatory response to fentanyl in patients with OSA Specifically: respiratory changes, CO2, RR, TV
Patients with sleep apnea having oxygen Saturation <85% randomized to 1.5 mcg/kg fentanyl
Children with OSA having procedures requiring endotracheal intubation and a who will receive opioids (1.5 mcg/kg fentanyl for IBW, max 25 mcg) for evaluation of respiratory changes.
Fentanyl Citrate
Ventilatory response to fentanyl in patients with OSA Specifically: respiratory changes, CO2, RR, TV
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fentanyl Citrate
Ventilatory response to fentanyl in patients with OSA Specifically: respiratory changes, CO2, RR, TV
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ages 2 to up to 8 years
* Preoperative sleep study demonstrating obstructive sleep apnea
* Intubation without medication (e.g. no propofol prior to intubation)
* Requirement for airway instrumentation: LMA or ETT
* Inhalation induction of anesthesia
Exclusion Criteria
* Central sleep apnea events \>5/hour
* IV induction of anesthesia
* Syndromic patients
* Known or suspected difficult airway
* Allergy to Fentanyl
* Known cardiovascular medications
* Pulmonary hypertension
* Total intravenous anesthesia required
* Parental refusal
2 Years
8 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Houston
OTHER
Children's Hospital of Philadelphia
OTHER
Wake Forest University
OTHER
Baylor College of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Adam Adler MD, MS, FAAP
Associate Professor of Anesthesiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Texas childrens Hospital
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Adler AC, Chandrakantan A, Nathanson BH, von Ungern-Sternberg BS. An assessment of opioids on respiratory depression in children with and without obstructive sleep apnea. Paediatr Anaesth. 2021 Sep;31(9):977-984. doi: 10.1111/pan.14228. Epub 2021 Jun 16.
Adler AC, Lin EE, Messner AH, Rosenberg TL, Pecorella S, Keleghan A, Faircloth S, Templeton TW, Harris L, Khan SA, Pednekar GS, Nguyen DT, Chandrakantan A, von Ungern-Sternberg BS. Association of preoperative nocturnal hypoxaemia nadir and fentanyl ventilatory sensitivity in children with obstructive sleep apnoea undergoing general anaesthesia: multicentre clinical cohort study. Br J Anaesth. 2025 Sep 5:S0007-0912(25)00512-4. doi: 10.1016/j.bja.2025.07.059. Online ahead of print.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H50267
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.